Volumetric changes of the parotid gland during IMRT based on mid-treatment imaging: implications for parotid stem cell sparing strategies in head and neck cancer

References

• Fitzmaurice C, Allen C, Barber RM, Global Burden of Disease Cancer Collaboration, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and Disability-Adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–548.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69–90.
   PubMed Web of Science ®Google Scholar
• Kabarriti R, Brodin NP, Lundgren G, et al. Early response assessment on mid-treatment computed tomography predicts for locoregional recurrence in oropharyngeal cancer patients treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys. 2018;102(4):1036–1045.
   PubMed Web of Science ®Google Scholar
• Brodin NP, Kabarriti R, Pankuch M, et al. A quantitative clinical Decision-Support strategy identifying which patients with oropharyngeal head and neck cancer may benefit the most from proton radiation therapy. Int J Radiat Oncol Biol Phys. 2019;104(3):540–552.
   PubMed Web of Science ®Google Scholar
• Vissink A, Mitchell JB, Baum BJ, et al. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers. Int J Radiat Oncol Biol Phys. 2010;78(4):983–991.
   PubMed Web of Science ®Google Scholar
• Iorgulescu G. Saliva between normal and pathological. Important factors in determining systemic and oral health. J Med Life. 2009; 2(3):303–307.
   PubMedGoogle Scholar
• Deasy JO, Moiseenko V, Marks L, et al. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys. 2010;76(3):S58–S63.
   PubMed Web of Science ®Google Scholar
• van Luijk P, Pringle S, Deasy JO, et al. Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer. Sci Transl Med. 2015; 67(305):305.
   Google Scholar
• Steenbakkers R, van Rijn-Dekker MI, Stokman MA, et al. Parotid gland stem cell sparing radiation therapy for patients with head and neck cancer: a Double-Blind randomized controlled trial. Int J Radiat Oncol Biol Phys. 2022;112(2):306–316.
   PubMed Web of Science ®Google Scholar
• Deasy JO, Blanco AI, Clark VH. CERR: a computational environment for radiotherapy research. Med Phys. 2003;30(5):979–985.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Tucker SL. Quantifying the position and steepness of radiation dose-response curves. Int J Radiat Biol. 1997;71(5):531–542.
   PubMed Web of Science ®Google Scholar
• Astaburuaga R, Gabryś HS, Sánchez-Nieto B, et al. Incorporation of dosimetric gradients and parotid gland migration into xerostomia prediction. Front Oncol. 2019;9:697.
   PubMed Web of Science ®Google Scholar
• Ortholan C, Chamorey E, Benezery K, et al. Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function. Int J Radiat Oncol Biol Phys. 2009;73(1):178–186.
   PubMed Web of Science ®Google Scholar
• Moiseenko V, Wu J, Hovan A, et al. Treatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: an independent test of QUANTEC criteria using a prospectively collected dataset. Int J Radiat Oncol Biol Phys. 2012;82(3):1108–1114.
   PubMed Web of Science ®Google Scholar
• Meirovitz A, Murdoch-Kinch CA, Schipper M, et al. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;66(2):445–453.
   PubMed Web of Science ®Google Scholar
• Beetz I, Steenbakkers RJ, Chouvalova O, et al. The QUANTEC criteria for parotid gland dose and their efficacy to prevent moderate to severe patient-rated xerostomia. Acta Oncol. 2014; May53(5):597–604.
   PubMed Web of Science ®Google Scholar
• Beetz I, Schilstra C, van der Schaaf A, et al. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors. Radiother Oncol. 2012;105(1):101–106.
   PubMed Web of Science ®Google Scholar